The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, S. J.
Right arrow Articles by Clarke, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrison, S. J.
Right arrow Articles by Clarke, M. F.
The Journal of Immunology, 2002, 168: 635-642.
Copyright © 2002 by The American Association of Immunologists

A Genetic Determinant That Specifically Regulates the Frequency of Hematopoietic Stem Cells1

Sean J. Morrison*,{dagger},{ddagger}, Dalong Qian{dagger}, Libuse Jerabek§, Bonnie A. Thiel, In-Kyung Park{dagger}, Preston S. Ford{dagger}, Mark J. Kiel*,{dagger},{ddagger}, Nicholas J. Schork, Irving L. Weissman§ and Michael F. Clarke2,{dagger}

* Howard Hughes Medical Institute and Departments of {dagger} Internal Medicine and {ddagger} Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109; § Departments of Pathology and Developmental Biology, Stanford University, Stanford, CA 94305; and Department of Genetics and Center for Human Genetics, Case Western Reserve University, Cleveland, OH 44106


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The regulation of hematopoietic stem cell (HSC) homeostasis is not well understood. We screened for genetic polymorphisms that were linked to differences between mouse strains in the numbers of long-term reconstituting HSCs or restricted progenitors in the bone marrow. AKR/J mice had significantly higher frequencies and numbers of both HSCs and restricted progenitors in their bone marrow than C57BL/Ka-Thy-1.1 mice. The C57BL/Ka-Thy-1.1 alleles were partially dominant. A locus on chromosome 17, including the H-2 complex, was significantly linked to the frequency of long-term self-renewing HSCs but showed no evidence of linkage to the frequency of restricted progenitors. Conversely, a chromosome 1 locus exhibited suggestive linkage to restricted progenitor frequencies but was not linked to HSC frequency. This demonstrates that there are distinct genetic determinants of the frequencies of HSCs and restricted progenitors in vivo. The AKR/J chromosome 17 locus was not sufficient to increase HSC frequencies when bred onto a C57BL background. This suggests that to affect HSC frequencies, the product(s) of this locus likely depend on interactions with unlinked modifying loci.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Hematopoietic stem cells (HSCs)3 have three important properties that explain the lifelong perpetuation of hematopoiesis and the remarkable regenerative capacity of the hematopoietic system: extensive self-renewal potential, pluripotency, and frequent cell cycle quiescence. The genetic regulation of these properties is poorly understood. Insights into the genetic regulation of HSCs have mainly come from the phenotypes of spontaneously occurring mutations or gene-targeted mice. For example, deficiencies in steel factor or its receptor (1), thrombopoietin receptor (2), or Ikaros (3) lead to reductions in the numbers and frequencies of HSCs and progenitors in the bone marrow. These loss of function studies identify genes that regulate the survival, proliferation, or differentiation of hematopoietic progenitors.

An alternate approach is to identify the genes that cause HSC properties to vary among different genetic backgrounds. Van Zant and colleagues (4, 5, 6) showed that the cell cycle kinetics and/or self-renewal of HSCs varies among different mouse strains and that such variations have important effects on HSC population dynamics; furthermore, the numbers of primitive hematopoietic progenitors vary considerably between mouse strains based on differences in the frequencies of long-term culture-initiating cells (LTC-IC) (7) and cobblestone area-forming cells (CAFC) (8, 9). Muller-Sieburg and Riblet (7) found that differences in mouse LTC-IC frequency were associated with polymorphisms at one or two loci on chromosome 1. de Haan and Van Zant (9, 10) found that the frequency of day 35 CAFC was significantly linked to a 4-cM interval of chromosome 18 and exhibited suggestive linkage to additional loci on chromosomes 2, 14, and X. It is important to identify the genetic determinants of HSC frequency in bone marrow because HSC frequency reflects several aspects of HSC regulation, and the ability to increase HSC numbers would greatly facilitate potential clinical applications using HSCs.

Factors that modulate the frequency of HSCs in vivo usually modulate the frequencies of restricted progenitors as well. Administration of cytokines such as steel factor and G-CSF with or without cytoreductive drugs can lead to an increase in HSC frequency (11, 12, 13); however, the same treatments concomitantly increase the frequency of a wide variety of committed progenitors (14, 15). The transcription factor GATA-2 is required in both HSCs and mast cell precursors (16, 17, 18). Mutation of the SCL/tal-1 transcription factor eliminates all hematopoiesis (19) but, in addition to regulating the formation or maintenance of HSCs, it may independently regulate restricted progenitors (20). The tyrosine kinase flk2/flt3 was thought to be a specific regulator of multipotent progenitors (21, 22) but later was found to regulate committed B lineage progenitors as well (23). In contrast, recent studies of cyclin-dependent kinase inhibitors provide the first evidence of a distinction in cell cycle regulation between HSCs and restricted progenitors: p21 deficiency increased the frequency and proliferation of HSCs (24), while p27 deficiency increased the frequency and proliferation of restricted progenitors (25).

We demonstrate that AKR/J mice have more long-termreconstituting HSCs than C57BL/Ka-Thy-1.1 mice. We systematically examined long-term self-renewing HSC frequencies in (C57BL/Ka-Thy-1.1 x AKR/J)F2 mice and genotyped them by PCR sequence length polymorphisms generated using primers to sequence tags distributed throughout the genome. By identifying polymorphisms that were statistically significantly linked to HSC frequencies we demonstrate that variations in HSC frequency were determined by a locus on chromosome 17. This locus specifically influenced HSC frequency but not the frequency of more restricted progenitors which were regulated by a distinct locus on chromosome 1. These data support the idea that HSCs and restricted hematopoietic progenitors are independently regulated by distinct sets of genes.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Mouse strains

C57BL/6J (Ly5.1), C57BL/Ka-Thy1.1 (Ly 5.2), AKR/J, AKR/cumberland, C57BL-FlaEg.Thy-1.1, and (C57BL/Ka x AKR/J)F1 and F2 mice were bred and maintained at the Stanford University Medical Center (Stanford, CA). All mice were maintained on acidified water (pH 2.5). HSC frequency was analyzed in the bone marrow of 6- to 10-wk-old mice. CAFC frequency was assayed in 4- to 8-mo-old mice. Recipient mice in reconstitution assays were 8–14 wk old at the time of irradiation.

Bone marrow preparation and staining

Marrow was flushed from the femurs and tibias of donor mice. Single cell suspensions were prepared by drawing the bone marrow through a 25-gauge needle, then expelling them back through a nylon mesh screen. Cells were suspended in HBSS (without phenol red; Applied Scientific, San Francisco, CA) containing 2% calf serum (Irvine Scientific, Santa Ana, CA), pH 7.2. Marrow samples from individual mice were always processed separately, not pooled.

For HSC purification or analysis, cells were incubated with a mixture of unlabeled lineage marker Abs including those specific for CD3 (KT31.1), CD4 (GK1.5), CD5 (53-7.3), CD8 (53-6.7), Gr-1 (8C5), Ly-76 (Ter119), B220 (6B2), and Mac-1 (M1/70). All Ab incubations were 20 min on ice. After incubation, cells were diluted and centrifuged through a calf serum cushion. The cells were incubated with a PE-conjugated anti-rat IgG Ab to stain lineage markers. The cells were then incubated with directly conjugated Abs against Thy-1.1 (19 x E5FITC), Sca-1 (E13bio), and c-kit (2B8APC). The cells were resuspended in 0.5 µg/ml propidium iodide before analysis. Analyses and cell sorts were performed on a modified dual laser FACS (BD Biosciences, Mountain View, CA). For functional assays, progenitors were purified by sorting and resorting to obtain precise numbers of cells that were homogeneous for the indicated surface marker phenotype.

Functional analyses

Recipient mice were lethally irradiated (920 rad for C57BL, 800 rad for AKR/Cu) using an x-ray machine operated at 200 kV, delivering 85 rad/min. The radiation was delivered in two doses, with ~3 h between doses. After irradiation, mice were maintained on antibiotic water containing 1.1 g/L neomycin sulfate and 106 U/L polymixin B sulfate. For reconstitution assays, double-sorted progenitor populations were injected into the retro-orbital venous sinus of irradiated recipient mice along with recipient type whole bone marrow (WBM) cells (200,000 for C57BL and 40,000–200,000 for AKR due to the higher frequency of multipotent progenitors) to protect recipient mice from radiation-induced hematopoietic failure. Reconstituted mice were periodically bled via the tail vein to monitor reconstitution by donor marked progenitors. RBCs were depleted by sedimentation and the remaining RBCs were lysed by a 5-min incubation on ice in 0.15 M ammonium chloride plus 0.01 M potassium bicarbonate. Cells were stained with three color combinations of Abs against a donor marker (Ly5.2 for C57BL and Thy-1.1 for AKR) and lineage markers and analyzed by flow cytometry.

Stromal cell cultures were prepared by plating AC-6 cells in 24-well plates. After the AC-6 cells became confluent, the cultures were irradiated and single Thy-1lowSca-1+Lineage (Lin)-c-kit+ cells were sorted into each well. The medium (RPMI 1640, 10% FBS, 50 µM 2-ME, penicillin/streptomycin, and 1 µM sodium pyruvate) was changed weekly. Colony formation was monitored using an inverted microscope from 1 to 6 wk after cloning HSCs into the cultures. All cultures were incubated at 37°C in a humidified chamber flushed with 5% CO2.

CAFC were also assayed on AC-6 stromal feeder cells in 12-well plates. Five thousand- and 10,000-cell aliquots of bone marrow harvested from the tibia of 4- to 8-mo-old mice were added to duplicate wells confluent with AC-6 stroma. On day 4, 80% of the culture medium was removed and replaced with fresh medium. Cobblestone colonies of >50 cells were counted. Colonies containing only macrophages were not counted.

Genetic screen

Genomic DNA was prepared from liver or tail samples. PCR amplification of simple sequence repeats (microsatellites) and gel electrophoresis was performed as described (26), with minor modifications (27). Primer pairs mapped to the mouse genome (Genetic Map of the Mouse, Database Release 10, Massachusetts Institute of Technology Center for Genome Research, Cambridge, MA) were purchased from Research Genetics (Huntsville, AL).

Genotype data from (C57BL/Ka-Thy-1.1 x AKR/J)F2 mice exhibiting parental frequencies of HSCs or day 8 CAFC were assessed for association using a standard likelihood ratio test for contingency tables (28). Markers showing evidence for skewing of genotypes across the mice with high and low HSC frequencies were then subjected to a second analysis in which more mice were genotyped at the skewed marker as well as at additional nearby markers. Likelihood ratios were converted to logarithm (base 10) of odds of association (LOD) scores and significance levels checked against the criteria described by Lander and Kruglyak (29).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
AKR/J Thy-1lowSca-1+Lin-c-kit+ cells are highly enriched for long-term reconstituting HSC activity

Long-term reconstituting HSCs can be isolated as Thy-1lowSca-1+Lin-c-kit+ cells (30, 31, 32) from mouse strains with the Thy-1.1, Ly-6b genotype (33, 34). Both C57BL/Ka-Thy-1.1 and AKR/J mice are Thy-1.1, Ly-6b. Thy-1lowSca-1+Lin-c-kit+ cells from C57BL/Ka mice are highly enriched for long-term multilineage reconstituting activity. Based on limit dilution analyses, lethally irradiated C57BL-Ly5.2 mice were competitively reconstituted on average by a single long-term self-renewing multipotent progenitor when injected i.v. with 13 Thy-1lowSca-1+Lin-c-kit+ cells from C57BL/Ka-Thy-1.1 mice (31, 35, 36). The Thy-1lowSca-1+Lin-c-kit+ population from C57BL/Ka-Thy-1.1 mice is thought to be a nearly pure population of long-term reconstituting HSCs because nearly 80% of limit dilution reconstituted mice were long-term multilineage reconstituted (31), ~90% of single cells formed primitive colonies in methylcellulose, and 49% of single cells formed long-term colonies on AC-6 stroma (13, 32, 37, 38).

Thy-1lowSca-1+Lin-c-kit+ cells purified from AKR/J were phenotypically indistinguishable from the long-term reconstituting HSC population in C57BL/Ka-Thy-1.1 (Fig. 1Go). As expected based on their genotype, AKR/J Thy-1lowSca-1+Lin-c-kit+ cells were also highly enriched for long-term reconstituting HSCs. Male AKR/J Thy-1lowSca-1+Lin-c-kit+ cells were competed against 40,000–200,000 female AKR/cumberland WBM cells and assayed for reconstituting activity in lethally irradiated female AKR/Cu mice. AKR/Cu are Thy-1.2, thus reconstitution by AKR/J donor HSCs was detected by the presence of Thy-1.1+ T cells and by Y chromosome-containing myeloid and B cells. In many experiments with Thy-1lowSca-1+Lin-c-kit+ cells from C57BL/Ka-Thy-1.1 mice, recipients that were reconstituted by donor T cells were always multilineage reconstituted. Thus AKR/Cu mice were assayed for reconstitution by screening for donor T cells by FACS between 3 and 6 mo after reconstitution. In two experiments, 11 of 16 recipients of 10 donor Thy-1lowSca-1+Lin-c-kit+ cells had donor T cells at 13–14 wk after reconstitution. Two of three recipients injected with 15 Thy-1lowSca-1+Lin-c-kit+ cells were reconstituted by donor T cells at 6 mo and eight of nine recipients injected with 50 cells were reconstituted by donor T cells at 14 wk after reconstitution. It was confirmed that recipients of 10 or 50 donor Thy-1lowSca-1+Lin-c-kit+ cells that became reconstituted by donor T cells were multilineage reconstituted. Myeloid and B cells were purified by flow cytometry from the blood of recipients and tested for Y chromosome by PCR. As shown in Fig. 2Go, every recipient that was reconstituted by donor T cells was also reconstituted by donor myeloid and B cells. By limit dilution analysis, recipients were reconstituted by an average of one long-term HSC when injected with 11 cells (Table IGo). Thus AKR/J Thy-1lowSca-1+Lin-c-kit+ cells were similarly highly enriched for long-term multilineage reconstituting activity as the corresponding population from C57BL/Ka mice.



View larger version (28K):
[in this window]
[in a new window]
  		FIGURE 1. Phenotypically indistinguishable Thy-1lowSca-1+Lin-c-kit+ cells are present in both C57BL and AKR/J mice. Thy-1lowSca-1+Lin-c-kit+ cells with indistinguishable surface marker phenotypes and light scatter properties can be purified from C57BL/Ka-Thy-1.1 and AKR/J mice. Thy-1lowSca-1+Lin-c-kit+ cells were purified by FACS from C57BL/Ka-Thy-1.1 and AKR/J bone marrow. Fluorescence profiles of WBM cells are shown as open histograms, while the reanalysis of sorted Thy-1lowSca-1+Lin-c-kit+ cells is shown in filled histograms.

 


View larger version (75K):
[in this window]
[in a new window]
  		FIGURE 2. AKR/J Thy-1lowSca-1+Lin-c-kit+ cells are highly enriched for long-term multilineage reconstituting activity. Female AKR/Cu mice were competitively reconstituted by 10 or 50 male AKR/J Thy-1lowSca-1+Lin-c-kit+ cells along with a radioprotective dose (50,000–200,000) of female AKR/Cu bone marrow. Recipients were tested for the presence of Thy-1.1+ (donor type) T cells by FACS at 13 wk after reconstitution. At 16 wk after reconstitution, 7,000–50,000 myeloid cells and 65,000–79,000 B cells were purified from the blood of recipients by FACS. DNA was isolated from these cells and the presence of Y chromosome DNA was assayed by PCR amplification using Y chromosome-specific primers. Lanes 1 and 15, 100-bp ladder; lane 2, positive control (male (C57BL x AKR)F2); lanes 3 and 4, negative control (female AKR/Cu mice); lanes 5 and 6, female AKR/Cu injected with 10 male AKR/J Thy-1lowSca-1+Lin-c-kit+ cells; lanes 7–14, female AKR/Cu injected with 50 male AKR/J Thy-1lowSca-1+Lin-c-kit+ cells. All mice that contained donor type T cells (assayed by FACS) also contained donor type myeloid and B cells (assayed by PCR). Mice corresponding to lanes 6 and 8 were not detectably reconstituted by donor T cells but did have detectable donor type myeloid and/or B cells. Such oligopotent reconstitution was also observed in a minority of mice reconstituted by limit dilution doses of C57BL/Ka Thy-1lowSca-1+Lin-c-kit+ cells (31 ).

 

View this table:
[in this window]
[in a new window]
  		Table I. The properties of Thy-1lowSca-1+Lin-c-kit+ cells from C57BL/Ka-Thy-1.1 and AKR/J mice1

 
At least some AKR/J Thy-1lowSca-1+Lin-c-kit+ cells had day 12 CFU-spleen (CFU-S) activity (Table IGo), as would be expected for a long-term HSC population under our assay conditions (31, 39, 40). While AKR/J Thy-1lowSca-1+Lin-c-kit+ cells appeared to have somewhat more CFU-S activity than the corresponding C57BL/Ka population, the significance of this is hard to interpret because the CFU-S activity of HSCs probably varies by cell cycle status and mouse strain. Fifty-six percent of single AKR/J Thy-1lowSca-1+Lin-c-kit+ cells formed colonies of hundreds of thousands of hematopoietic cells that persisted for >6 wk on AC-6 stromal cells, as compared with 49% of cells from the same C57BL/Ka population.

AKR/J mice have more HSCs than C57BL/Ka-Thy-1.1 mice

We compared the frequencies of bone marrow HSCs between AKR/J and C57BL/Ka-Thy-1.1 mice. In addition to determining the frequencies of Thy-1lowSca-1+Lin-c-kit+ cells, which contain mainly long-term reconstituting HSCs, we compared the frequencies of Thy-1lowSca-1+Lin-/lowc-kit+ cells, which contain mainly transiently reconstituting multipotent progenitors (31). There was no difference in the total number of bone marrow cells that could be recovered from the femurs and tibia of AKR/J (8.72 ± 0.2 x 107 cells) and C57BL/Ka-Thy-1.1 mice (8.99 ± 0.2 x 107 cells). In side-by-side pairwise comparisons, AKR/J averaged four times as many Thy-1lowSca-1+Lin-c-kit+ cells and nearly three times as many Thy-1lowSca-1+Lin-/lowc-kit+ cells as C57BL/Ka-Thy-1.1 (Table IIGo). Both differences were highly statistically significant (p < 0.001). Because Thy-1lowSca-1+Lin-c-kit+ cells are similarly enriched for long-term reconstituting HSCs in AKR/J and C57BL/Ka-Thy-1.1 mice, we conclude that AKR/J mice have four times as many long-term reconstituting HSCs and significantly more transiently reconstituting multipotent progenitors as well.


View this table:
[in this window]
[in a new window]
  		Table II. The frequencies of multipotent progenitors in C57BL/Ka-Thy-1.1 and AKR/J mice

 
Analysis of HSC frequency in (C57BL/Ka-Thy-1.1 x AKR/J)F1 progeny

AKR/J mice were bred with C57BL/Ka-Thy-1.1 mice and the frequency of Thy-1lowSca-1+Lin-c-kit+ HSCs was assayed in the bone marrow of the femurs and tibias of the F1 mice (Table IIIGo). Of 12 F1 mice examined, four mice had HSC frequencies that fell around the high end of the C57BL/Ka-Thy-1.1 range (0.014–0.016). All remaining mice were intermediate between the C57BL/Ka-Thy-1.1 and AKR/J ranges. No F1 mice had HSC frequencies within or near the AKR/J range. The F1 data demonstrate that the C57BL/Ka-Thy-1.1 alleles of polymorphic gene(s) that influence HSC frequency are partially dominant.


View this table:
[in this window]
[in a new window]
  		Table III. The frequency of Thy-1lowSca-1+Lin-c-kit+ cells in individual C57BL/Ka-Thy-1.1, AKR/J, and (C57BL/Ka-Thy-1.1 x AKR/J)F1 mice

 
Analysis of HSC frequency in F2 progeny

The frequencies of Thy-1lowSca-1+Lin-c-kit+ cells were assayed in 290 (C57BL/Ka-Thy-1.1 x AKR/J)F2 mice (Table IVGo). Within each analysis, bone marrow cells from C57BL/Ka and AKR/J mice were analyzed for comparison. Of 32 C57BL/Ka-Thy-1.1 controls analyzed, 29 fell within the normal low range, while three had HSC frequencies intermediate to those normally seen in C57BL/Ka-Thy-1.1 and AKR/J. Of 28 AKR/J mice examined, 26 had HSC frequencies that fell within their normal high range while two mice had intermediate HSC frequencies. Of the F2 mice examined, 32% had low HSC frequencies that were equal to or less than normal C57BL/Ka-Thy-1.1 controls, 12% had high HSC frequencies that were equal to or greater than normal AKR/J controls, and 56% had intermediate HSC frequencies.


View this table:
[in this window]
[in a new window]
  		Table IV. Distribution of (C57BL/Ka-Thy-1.1 x AKR/J)F2 mice between low, intermediate, and high frequencies of HSC

 
Interval mapping of F2 progeny

The genome was scanned to identify chromosome regions that contain genes that regulate HSC frequency. Seventy-six markers spanning the genome (including the X chromosome but not the Y chromosome) were assessed for linkage to HSC frequency in a screen that used F2 mice with low or high HSC frequencies. The genome scan was initially done using DNA isolated from 10 F2 mice with high and 10 F2 mice with low Thy-1lowSca-1+Lin-c-kit+ cell frequencies (indistinguishable from the AKR/J or C57BL/Ka-Thy-1.1 parental mice, respectively). Twenty-six F2 mice with high HSC frequencies and 42 F2 mice with low HSC frequencies were then genotyped using a number of markers near several loci that showed evidence of linkage in the initial screen. Ultimately, only one locus showed suggestive or significant linkage to HSC frequency: a region of chromosome 17, around the marker D17 Mit65 (Table VGo). Assuming a partial dominance model, this association was highly significant (p < 0.001). Neighboring markers D17 Mit65 and D17 Mit66 exhibited LOD scores of 4.85 and 4.64, respectively, based on a likelihood ratio test of association for contingency tables (28). Both markers exhibited significant linkage based on criteria for intercross analysis (29).


View this table:
[in this window]
[in a new window]
  		Table V. Significant linkage of HSC frequency to genotype at chromosome 17 loci based on an analysis of (C57BL/Ka-Thy-1.1 x AKR/J)F2 mice with parental (C57BL or AKR) HSC frequencies1

 
The influence of the chromosome 17 locus is specific to HSCs

We sought to test whether the locus linked to D17 Mit66 influenced progenitor numbers generally or if its effect was specific to HSCs. The frequency of restricted progenitors can be quantified in CAFC assays by counting the number of progenitors that form cobblestone areas at early time points from 7 to 10 days (41, 42). The frequencies of day 8 CAFC were 16.1 ± 6.3/104 WBM cells in C57BL/Ka-Thy-1.1 (n = 14) and 26.5 ± 15.0/104 WBM cells in AKR/J (n = 15). This difference was statistically significant (p = 0.02). The day 8 CAFC frequencies we observed were consistent with a previous report (41). Unfortunately, the surface marker phenotypes of restricted progenitors that form day 8 cobblestone areas are not characterized, so this difference in day 8 CAFC cannot be confirmed by assaying for a corresponding difference in the frequency of a phenotypically defined restricted progenitor population. Nonetheless, we assayed for differences in the frequencies of pro-B cells (B220+CD43highIgM- (43)), common myeloid progenitors (Lin-IL-7R-c-kit+Sca-1-FcRlow (44)) and common lymphoid progenitors (Lin-IL-7R+c-kitlowSca-1low (45)). We did not observe a difference in the frequency of these progenitor populations between AKR/J and C57BL/Ka-Thy-1.1 (data not shown). This suggests that not all progenitor frequencies are regulated differently between these two mouse strains, and provides further evidence that polymorphisms that influence HSC frequencies do not have global effects on all progenitors.

(C57BL/Ka-Thy-1.1 x AKR/J)F2 mice were assayed for day 8 CAFC frequencies. F2 mice were then categorized as low (day 8 CAFC <10/104 WBM cells), intermediate, or high (day 8 CAFC >25/104 WBM cells). These mice were then genotyped at selected markers to determine whether loci that were potentially linked to HSC frequency were also linked to restricted progenitor frequency. Table VIGo shows that D17 Mit66 was not linked to day 8 CAFC frequency. Thus, while loci linked to D17 Mit66 influenced HSC frequency, there was no evidence that they influenced the frequencies of more restricted progenitors. D17 Mit65, which is only 0.1 cM away from D17 Mit66, was not genotyped in these mice.


View this table:
[in this window]
[in a new window]
  		Table VI. No evidence for linkage of day 8 CAFC frequency to genotype at D17 Mit66 based on an analysis of (C57BL/Ka-Thy-1.1 x AKR/J)F2 mice with parental levels of day 8 CAFC1

 
Restricted hematopoietic progenitors are regulated by a distinct locus

Genotyping of F2 mice with high and low day 8 CAFC frequencies led to the identification of a chromosome 1 locus that appears to influence restricted progenitor frequencies but not HSC frequencies. D1 Mit330 is a marker located around 35 cM on chromosome 1. Table VIIGo shows that when the D1 Mit330 marker was tested for linkage to day 8 CAFC, a LOD score of 2.8 was generated based on a likelihood ratio test of association. This satisfies the criterion for suggestive linkage in an intercross analysis (29). D1 Mit330 showed no evidence of linkage to HSC frequency (Table VIIGo).


View this table:
[in this window]
[in a new window]
  		Table VII. Linkage of day 8 CAFC but not HSC frequency to genotype at D1 Mit330 based on an analysis of (C57BL/Ka-Thy1.1 x AKR/J)F2 mice1

 
Mapping of the chromosome 17 locus that influences HSC frequency

Additional markers at 5-cM intervals from 9.8 to 49.2 cM on chromosome 17 were genotyped in (C57BL/Ka-Thy-1.1 x AKR/J)F2 mice that had high or low HSC frequencies. The first six markers (D17 Mit 31, 51, 65, 66, 139, and 87) all exhibited significant linkage to HSC frequency (LOD >= 4.3). The next two markers, D17 Mit153 (at 35 cM) and D17 Mit186 (at 39 cM), exhibited suggestive linkage, while the final marker, D17 Mit155 (49 cM), was not linked to HSC frequency. The resulting linkage map is shown in Fig. 3Go. It demonstrates that at least 20 cM of chromosome 17 proximal to the 30 cM point are significantly linked to HSC frequency. Note that marker positions are based on the Massachusetts Institute of Technology Center for Genome Research website (www.genome.wi.mit.edu). The Jackson Laboratory (Bar Harbor, ME) mouse genome database (www.informatics.jax.org) reports somewhat different positions but is based on analyses of a more distant genetic background.



View larger version (14K):
[in this window]
[in a new window]
  		FIGURE 3. A 20 cM region of chromosome 17 was significantly linked to the frequency of HSCs. Markers averaging 5-cM intervals on chromosome 17 were genotyped in 65 (C57BL x AKR)F2 mice with high or low HSC frequencies. The dashed line shows the LOD score criterion for significant linkage (29 ). The genotyped markers are shown on the x-axis. The approximate locations of markers in centimorgans (based on the Massachusetts Institute of Technology database, www.genome.wi.mit.edu) are shown for some markers. Note that the precise locations of individual markers in an AKR/J x C57BL background is unknown because markers have principally been mapped in other genetic backgrounds, often involving crosses with M. spretus. For similar reasons, precise locations for individual genes relative to these markers is unknown, but approximate locations are indicated for several genes that are located within the linked region.

 
The AKR/J chromosome 17 locus is not sufficient to increase HSC frequency in a C57BL background

To test whether the AKR/J chromosome 17 locus is sufficient to increase HSC frequencies, the AKR/J chromosome 17 locus between markers D17 Mit31 and D17 Mit87 was bred onto a C57BL background. To do this, C57BL-FlaEg.Thy-1.1 mice were obtained by mating B6.AKR-H2k/FlaEg mice (The Jackson Laboratory) to C57BL/Ka-Thy-1.1 mice and selecting offspring that retained both the Thy1.1 marker and the AKR/J-derived H-2 region from B6.AKR-H2k/FlaEg. B6.AKR-H2k/FlaEg mice are a congenic strain in which the H-2 region from AKR/J has been introduced onto a C57BL background. The AKR/J H-2 region for which the B6.AKR-H2k/FlaEg mice are congenic appears to closely correspond to the region exhibiting significant linkage in Fig. 3Go. That is, these mice were genotyped at all markers from D17 Mit31 to D17 Mit155 and had the AKR allele at all loci that exhibited linkage (D17 Mit31 to D17 Mit87) but had the C57BL allele at the loci that did not exhibit significant linkage: D17 Mit153, 186, and 155 (see Fig. 3Go). Thus, the C57BL-FlaEg.Thy-1.1 mice represent a C57BL background equivalent to C57BL/Ka-Thy-1.1, except that they contain the AKR/J H-2 region that exhibited linkage to increased HSC frequencies.

The frequencies of Thy-1lowSca-1+Lin-c-kit+ long-term reconstituting HSCs and Thy-1lowSca-1+Lin-/lowc-kit+ transiently reconstituting multipotent progenitors were significantly higher in AKR/J mice than in C57BL/Ka-Thy-1.1 or in C57BL-FlaEg.Thy-1.1 mice (Table VIIIGo). The frequencies of these two populations did not significantly differ between C57BL/Ka-Thy-1.1 and C57BL-FlaEg.Thy-1.1 mice. This suggests that the AKR/J H-2 region is not sufficient to increase HSC frequencies in a C57BL background. The most likely explanation for this is that the influence of linked gene(s) in this region depends on interactions with nonlinked modifying loci. Such loci were not detected in the initial screen, but because only 72 polymorphic markers throughout the genome were analyzed it is likely that additional loci that influence HSC frequencies were not detected. An alternative possibility is that the AKR/J chromosome 17 locus requires an AKR/J allele between D17 Mit87 (which exhibited significant linkage and had AKR alleles in C57BL-FlaEg.Thy-1.1 mice) and D17 Mit153 (which exhibited suggestive linkage and had C57BL alleles in C57BL-FlaEg.Thy-1.1 mice). That is, the linked region may have included an important gene distal to D17 Mit87 that was not included in the congenic region in the C57BL-FlaEg.Thy-1.1 mice. We were unable to generate a higher resolution map in this region because no informative markers were available between D17 Mit87 and D17 Mit153. Thus, it is possible that an AKR/J allele that was not present in the C57BL-FlaEg.Thy-1.1 congenic mice is required in this region to elevate HSC frequencies.


View this table:
[in this window]
[in a new window]
  		Table VIII. The AKR/J chromosome 17 locus that is significantly linked to high HSC frequencies is not sufficient to significantly increase HSC numbers when crossed onto a C57BL/Ka-Thy-1.1 background1

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
AKR/J mice have significantly greater numbers of long-term reconstituting HSCs and day 8 CAFC (restricted progenitors) than C57BL/Ka-Thy1.1 mice. By screening for linkages between genomic markers and the frequencies of HSCs and restricted progenitors in (C57BL/Ka-Thy1.1 x AKR/J)F2 mice, we found that differences in HSC number were significantly linked to a series of markers within a 20-cM region of chromosome 17; however, this locus was not linked to differences in day 8 CAFC frequencies. Thus, this locus influences the frequency of bone marrow HSCs but not the frequency of more restricted progenitors. The only other evidence of a regulator of HSC frequency but not restricted progenitor frequency came from recent studies of cyclin-dependent kinase inhibitors. p21 deficiency increased the frequency and proliferation of HSCs but not restricted progenitors (24), while p27 deficiency increased the frequency and proliferation of restricted progenitors (25). In support of the idea that HSCs and restricted progenitors are regulated by distinct genetic determinants we further demonstrated that a chromosome 1 locus influenced the frequency of restricted progenitors but not HSCs.

Polymorphisms in p21 do not appear to explain the difference in HSC frequency between AKR and C57BL mice. p21 has been sequenced in several inbred mouse strains, including AKR and C57BL, and the coding sequence was not observed to contain any polymorphisms that affected the amino acid sequence (46). To address whether there is any polymorphism in the promoter or regulatory elements that might affect the p21 expression level in AKR/J and C57BL/Ka, we compared p21 expression level in bone marrow by Western blot and found similar levels of expression (data not shown). To determine whether p21 is similarly up-regulated after irradiation in the two strains, p21 levels were examined by Western blot at 1, 3, and 4 h after irradiation of acutely isolated bone marrow suspensions. p21 was up-regulated normally in both mouse strains and continued to be expressed at similar levels (data not shown). These observations suggest that there are not polymorphisms in regulatory elements that cause detectable differences in the expression level of p21 in AKR/J and C57BL/Ka mice. Thus, while it remains possible that there are differences in p21 expression that are specific to HSCs, it seems unlikely that polymorphisms in p21 could account for the difference in HSC frequencies between AKR/J and C57BL/Ka mice.

The proportions of F2 mice with high and low HSC frequencies suggest that a single locus on chromosome 17 cannot explain all of the variation in HSC number between C57BL/Ka-Thy-1.1 and AKR/J mice. If a single locus with Mendelian inheritance patterns determined the differences in HSC frequency between AKR/J and C57BL/Ka-Thy-1.1, then F2 mice would be expected to be distributed 1:2:1 between low, intermediate, and high HSC frequencies. Instead we observed an ~3:6:1 ratio among F2 mice. It would appear that additional loci that were not detected in our screen also influence HSC frequencies. The influence of such loci could explain why the AKR chromosome 17 locus is not sufficient in a C57BL background to increase HSC frequencies.

Previous studies reported associations between genetic markers and the frequency of primitive hematopoietic progenitors. de Haan and Van Zant (9) looked for linkages between day 35 CAFC frequency and genetic markers in recombinant inbred strains of C57BL/6 and DBA/2. They reported that a 4-cM region of chromosome 18 was linked to CAFC frequency. We genotyped F2 mice at D18 Mit182, which is within 6 cM of the region identified by de Haan and Van Zant (9), but it showed no evidence of linkage to HSC frequency. Either D18 Mit182 was too far from the locus identified by de Haan and Van Zant (9) or the alleles in this region that influence HSC frequency are polymorphic between C57BL and DBA/2 but not AKR/J. Muller-Sieburg and Riblet (7) also examined C57BL x DBA/2 recombinant inbred strains for loci that influence primitive progenitor numbers, but they quantified primitive progenitors using the LTC-IC assay. They reported an association with two chromosome 1 loci, linked to Acrg at ~53 cM and Adprp at ~98 cM. An important question is whether the assays used in the three studies detect the same progenitors. Day 35 CAFC and LTC-IC cannot both accurately estimate HSC numbers, because Muller-Sieburg and Riblet (7) estimated based on LTC-IC that BALB/c had five times more HSCs than C57BL/6, while de Haan and Van Zant (8) estimated based on day 35 CAFC that BALB/c had fewer HSCs than C57BL/6. Trends in HSC frequencies based on day 35 CAFC measurements by de Haan and Van Zant (8) have been similar to trends that we have reported based on direct determination of the numbers of Thy-1lowSca-1+Lin-c-kit+ cells in this and previous studies (compare Refs. 8 and 38).

Mapping of the chromosome 17 locus that influences the number of long-term self-renewing HSCs indicates that markers within an ~20-cM region were significantly linked to HSC frequency. The large size of the linked region suggests that HSC frequency may be regulated by multiple genes in the region. Unfortunately, developing an accurate consensus map of markers and genes within this region of chromosome 17 is particularly difficult because it contains inversions which differentially suppress recombination between different species of mice. This means that observed map distances vary considerably (by around 5 cM) between different genetic backgrounds. The markers have not been mapped on an AKR x C57BL background, but approximate locations were assigned based on the Massachusetts Institute of Technology database (www.genome.wi.mit.edu). Note that somewhat different genetic distances are reported in the Mouse Genome Database (The Jackson Laboratory; www.informatics.jax.org) but these distances were based primarily on crosses between different species of mice (Mus spretus and Mus musculus). Thus only approximate locations can be assigned to the markers and genes in the AKR x C57BL background.

Although precise positions of genes in this region cannot be determined without specifically mapping them in an AKR x C57BL background, several interesting candidate genes do fall within the linked region. The most striking aspect of the region is that it includes the H-2 complex, which contains most histocompatibility genes and many genes that regulate immune responsiveness. These include class I MHC alleles that are targets of NK cells and that act as barriers to the allotransplantation of HSCs (47, 48). NK cells inhibit HSC engraftment without killing (49) but perhaps by the secretion of factors such as TNF. The lymphotoxin/TNF complex is also contained within the linked region. Lymphotoxins A and B and TNF are widely expressed by hematopoietic cells and are known to be polymorphic between C57BL and AKR (50, 51, 52). TNF inhibits HSC proliferation (53), and TNFR-deficient mice have elevated numbers of primitive hematopoietic progenitors (54). Further study will be required to determine whether these effects are specific to HSCs.

In addition to the H-2 complex, Notch3 and Notch4 (55) are also in the linked region. Notch receptors are intriguing because they regulate stem cell numbers in the nervous system by influencing whether the stem cells self-renew or differentiate (56, 57, 58). Furthermore, Notch activation promotes the survival and self-renewal of human HSCs in culture (59). Another factor contained within the linked region is vascular endothelial growth factor (VEGF), which binds to receptors Flk-1 and Flt-1. Flk-1-deficient mice have greatly reduced numbers of hematopoietic progenitors and fail to form yolk sac blood islands (60). VEGF receptors are expressed by human HSCs (61), and VEGF protected human progenitors from radiation-induced cell death (62). Mechanisms that might account for the partially dominant role of the C57BL allele in reducing HSC numbers would be relatively complex, unless there is a clear dose response relationship of HSC to Notch or Flk-1 activation.

It is tempting to speculate that the alleles that account for the increased frequency of HSCs are also involved in the greatly increased incidence and early onset of lymphoma in AKR mice (63). The linked region contains two ubiquitously expressed cell cycle regulators, p21 (cyclin-dependent kinase inhibitor 1A, a tumor suppressor gene) and cyclin F (64, 65). Protooncogenes in the region include Pim1 (66), Pim2 (67), and vav (68). Each is known to be expressed in hematopoietic cells, and at least Pim1 is polymorphic between AKR and C57BL.

Although the AKR chromosome 17 region was not sufficient to increase HSC numbers in a C57BL background, perhaps it would be sufficient to increase HSC frequencies in other genetic backgrounds that are associated with low HSC frequencies. If so, it may be possible to positionally clone the polymorphic genes that affect HSC frequency on chromosome 17 by breeding this locus onto other genetic backgrounds.


   Acknowledgments
 
We thank Tim Knaak for FACS operation, Veronica Braunstein for Ab preparation, and Lucino Hidalgo and Bert Lavarro for animal care. Thanks to Jennifer Sanderson for secretarial assistance and to Dr. Douglas Wright for help in the preparation of Fig. 1Go.


   Footnotes
 
1 This work was supported by National Cancer Institute Grants CA42551 and DK53074 (to I.L.W.) and CA67140 (to M.F.C.). S.J.M. was a Howard Hughes Medical Institute Predoctoral Fellow when this work was started and is now an Assistant Investigator. Back

2 Address correspondence and reprint requests to Dr. Michael F. Clarke, Department of Internal Medicine, University of Michigan, 4310 Comprehensive Cancer Geriatric Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109. E-mail address: mclarke{at}umich.edu Back

3 Abbreviations used in this paper: HSC, hematopoietic stem cell; CAFC, cobblestone area-forming cell; CFU-S, CFU-spleen; LOD, logarithm (base 10) of odds of association; LTC-IC, long-term culture-initiating cell; Lin, lineage; VEGF, vascular endothelial growth factor . Back

Received for publication August 14, 2001. Accepted for publication November 6, 2001.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Ikuta, K., I. L. Weissman. 1992. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc. Natl. Acad. Sci. USA 89:1502.[Abstract/Free Full Text]
  2. Kimura, S., A. W. Roberts, D. Metcalf, W. S. Alexander. 1998. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin. Proc. Natl. Acad. Sci. USA 95:1195.[Abstract/Free Full Text]
  3. Nichogiannopoulou, A., M. Trevisan, S. Neben, C. Friedrich, K. Georgopoulos. 1999. Defects in hematopoietic stem cell activity in Ikaros mutant mice. J. Exp. Med. 190:1201.[Abstract/Free Full Text]
  4. Phillips, R. L., A. J. Reinhart, G. Van Zant. 1992. Genetic control of murine hematopoietic stem cell pool sizes and cycling kinetics. Proc. Natl. Acad. Sci. USA 89:11607.[Abstract/Free Full Text]
  5. Van Zant, G., P. W. Eldridge, R. R. Behringer, M. J. Dewey. 1983. Genetic control of hematopoietic kinetics revealed by analyses of allophenic mice and stem cell suicide. Cell 35:639.[Medline]
  6. Van Zant, G., B. P. Holland, P. W. Eldridge, J.-J. Chen. 1990. Genotype-restricted growth and aging patterns in hematopoietic stem cell populations of allophenic mice. J. Exp. Med. 171:1547.[Abstract/Free Full Text]
  7. Muller-Sieburg, C. E., R. Riblet. 1996. Genetic control of the frequency of hematopoietic stem cells in mice: mapping of a candidate locus to chromosome 1. J. Exp. Med. 183:1141.[Abstract/Free Full Text]
  8. de Haan, G., W. Nijhof, G. Van Zant. 1997. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood 89:1543.[Abstract/Free Full Text]
  9. de Haan, G., G. Van Zant. 1997. Intrinsic and extrinsic control of hemopoietic stem cell numbers: mapping of a stem cell gene. J. Exp. Med. 186:529.[Abstract/Free Full Text]
  10. de Haan, G., G. Van Zant. 1999. Dynamic changes in mouse hematopoietic stem cell numbers during aging. Blood 93:3294.[Abstract/Free Full Text]
  11. Bodine, D. M., N. E. Seidel, K. M. Zsebo, D. Orlic. 1993. In vivo administration of stem cell factor to mice increases the absolute number of pluripotent hematopoietic stem cells. Blood 82:445.[Abstract/Free Full Text]
  12. Bodine, D., N. E. Seidel, D. Orlic. 1996. Bone marrow collected 14 days after in vivo administration of granulocyte colony-stimulating factor and stem cell factor to mice has 10-fold more repopulating ability than untreated bone marrow. Blood 88:89.[Abstract/Free Full Text]
  13. Morrison, S. J., D. Wright, I. L. Weissman. 1997. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc. Natl. Acad. Sci. USA 94:1908.[Abstract/Free Full Text]
  14. Molineux, G., A. Migdalska, M. Szmitkowski, K. Zsebo, T. M. Dexter. 1991. The effects on hematopoiesis of recombinant stem cell factor (Ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte-colony-stimulating-factor. Blood 78:961.[Abstract/Free Full Text]
  15. Yamamoto, Y., R. Yasumizu, Y. Amou, N. Watanabe, N. Nishio, J. Toki, S. Fukuhara, S. Ikehara. 1996. Characterization of peripheral blood stem cells in mice. Blood 88:445.[Abstract/Free Full Text]
  16. Tsai, F.-Y., G. Keller, F. C. Kuo, M. Weiss, J. Chen, M. Rosenblatt, F. W. Alt, S. H. Orkin. 1994. An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371:221.[Medline]
  17. Nagai, T., H. Harigae, H. Ishihara, H. Motohashi, N. Minegishi, S. Tsuchiya, N. Hayashi, L. Gu, B. Andres, J. D. Engel, M. Yamamoto. 1994. Transcription factor GATA-2 is expressed in erythroid, early myeloid, and CD34+ human leukemia-derived cell lines. Blood 84:1074.[Abstract/Free Full Text]
  18. Tsai, F.-Y., S. H. Orkin. 1997. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89:3636.[Abstract/Free Full Text]
  19. Porcher, C., W. Swat, K. Rockwell, Y. Fujiwara, F. W. Alt, S. H. Orkin. 1996. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86:47.[Medline]
  20. Kallianpur, A. R., J. E. Jordan, S. J. Brandt. 1994. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood 83:1200.[Abstract/Free Full Text]
  21. Matthews, W., C. T. Jordan, G. W. Wiegand, D. Pardoll, I. R. Lemischka. 1991. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations. Cell 65:1143.[Medline]
  22. Zeigler, F. C., B. D. Bennett, C. T. Jordan, S. D. Spencer, S. Baumhueter, K. J. Carroll, J. Hooley, K. Bauer, W. Matthews. 1994. Cellular and molecular characterization of the role of the FLK-2/FLT-3 receptor tyrosine kinase in hematopoietic stem cells. Blood 84:2422.[Abstract/Free Full Text]
  23. Mackarehtschian, K., J. E. Hardin, K. A. Moore, S. Boast, S. P. Goff, I. R. Lemischka. 1995. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147.[Medline]
  24. Cheng, T., N. Rodrigues, H. Shen, Y.-G. Yang, D. Dombkowski, M. Sykes, D. T. Scadden. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287:1804.[Abstract/Free Full Text]
  25. Cheng, T., N. Rodrigues, D. Dombkowski, S. Stier, D. T. Scadden. 2000. Stem cell repopulation efficiency but not pool size is governed by p27kip1. Nat. Med. 6:1235.[Medline]
  26. Dietrich, W. F., J. C. Miller, R. G. Steen, M. Merchant, D. Damron, R. Nahf, A. Gross, D. C. Joyce, M. Wessel, R. D. Dredge, et al 1994. A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nat. Genet. 7:220.[Medline]
  27. Frankel, W. M., B. A. Taylor, J. L. Noebels, C. M. Lutz. 1994. Genetic epilepsy model derived from common inbred mouse strains. Genetics 138:481.[Abstract]
  28. Fineberg, S. E.. 1983. The Analysis of Cross-Classified Categorical Data MIT Press, Cambridge, MA.
  29. Lander, E. S., L. Kruglyak. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11:241.[Medline]
  30. Spangrude, G. J., S. Heimfeld, I. L. Weissman. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241:58.[Abstract/Free Full Text]
  31. Morrison, S. J., I. L. Weissman. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1:661.[Medline]
  32. Morrison, S. J., A. M. Wandycz, H. D. Hemmati, D. E. Wright, I. L. Weissman. 1997. Identification of a lineage of multipotent hematopoietic progenitors. Development 124:1929.[Abstract]
  33. Spangrude, G. J., D. M. Brooks. 1992. Phenotypic analysis of mouse hematopoietic stem cells shows a Thy-1-negative subset. Blood 80:1957.[Abstract/Free Full Text]
  34. Spangrude, G. J., D. M. Brooks. 1993. Mouse strain variability in the expression of the hematopoietic stem cell antigen Ly-6A/E by bone marrow cells. Blood 82:3327.[Abstract/Free Full Text]
  35. Henry, C., J. Marbrook, D. C. Vann, D. Kodlin, C. Wofsy. 1980. Limiting dilution analysis. B. B. Mishell, and S. M. Shiigi, eds. Selected Methods in Cellular Immunology 138. Freeman, San Francisco.
  36. Smith, L. G., I. L. Weissman, S. Heimfeld. 1991. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc. Natl. Acad. Sci. USA 88:2788.[Abstract/Free Full Text]
  37. Whitlock, C. A., G. F. Tidmarsh, C. Muller-Sieburg, I. L. Weissman. 1987. Bone marrow stromal cell lines with lymphopoietic activity express high levels of a pre-B neoplasia-associated molecule. Cell 48:1009.[Medline]
  38. Morrison, S. J., A. M. Wandycz, K. Akashi, A. Globerson, I. L. Weissman. 1996. The aging of hematopoietic stem cells. Nat. Med. 2:202.
  39. Spangrude, G. J., D. M. Brooks, D. B. Tumas. 1995. Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function. Blood 85:1006.[Abstract/Free Full Text]
  40. Morrison, S. J., D. E. Wright, S. H. Cheshier, I. L. Weissman. 1997. Hematopoietic stem cells: challenges to expectations. Curr. Opin. Immunol. 9:216.[Medline]
  41. Ploemacher, R. E., J. P. vanderSluijs, C. A. J. vanBeurden, M. R. M. Baert, P. L. Chan. 1991. Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. Blood 78:2527.[Abstract/Free Full Text]
  42. de Bruijn, M. F. T. R., R. E. Ploemacher, A. E. M. Mayen, J. S. A. Voerman, W. A. T. Slieker, W. van Ewijk, P. J. M. Leenen. 1996. High-level expression of the ER-MP58 antigen on mouse bone marrow hematopoietic progenitor cells marks commitment to the myeloid lineage. Eur. J. Immunol. 26:2850.[Medline]
  43. Hardy, R. R., C. E. Carmack, S. A. Shinton, J. D. Kemp, K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213.[Abstract/Free Full Text]
  44. Akashi, K., D. Traver, T. Miyamoto, I. L. Weissman. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193.[Medline]
  45. Kondo, M., I. L. Weissman, K. Akashi. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661.[Medline]
  46. Huppi, K., D. Siwarski, J. Dosik, P. Michieli, M. Chedid, S. Reed, B. Mock, D. Givol, J. F. Mushinski. 1994. Molecular cloning, sequencing, chromosomal localization and expression of mouse p21 (Waf1). Oncogene 9:3017.[Medline]
  47. Yu, Y. Y. L., V. Kumar, M. Bennett. 1992. Murine natural killer cells and graft-rejection. Annu. Rev. Immunol. 10:189.[Medline]
  48. Shizuru, J. A., L. Jerabek, C. T. Edwards, I. L. Weissman. 1996. Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment. Biol. Blood Marrow Transplant. 2:3.[Medline]
  49. Aguila, H. L., I. L. Weissman. 1996. HSC are not direct cytotoxic targets of natural killer cells. Blood 87:1225.[Abstract/Free Full Text]
  50. Gardner, S. M., B. A. Mock, J. Hilgers, K. E. Huppi, W. D. Roeder. 1987. Mouse lymphotoxin and TNF: structural analysis of the cloned genes, physical linkage, and chromosomal position. J. Immunol. 139:476.[Abstract]
  51. Montagutelli, X., T. Serikawa, J. L. Guenet. 1991. PCR-analyzed microsatellites: data concerning laboratory and wild-derived mouse inbred strains. Mamm. Genome 1:255.[Medline]
  52. Fowlis, G. A., S. Adelman, A. M. Knight, E. Simpson. 1992. PCR analyzed microsatellites of the mouse genome- additional polymorphisms among ten inbred mouse strains. Mamm. Genome 3:192.[Medline]
  53. Bryder, D., V. Ramsfjell, I. Dybedal, K. Theilgaard-Monch, C.-M. Hogerkorp, J. Adolfsson, O. J. Borge, S. E. W. Jacobsen. 2001. Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation. J. Exp. Med. 194:941.[Abstract/Free Full Text]
  54. Zhang, Y., A. Harada, H. Bluethmann, J. B. Wang, S. Nakao, N. Mukaida, K. Matsushima. 1995. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF{alpha}. Blood 86:2930.[Abstract/Free Full Text]
  55. Uyttendaele, H., G. Marazzi, G. Wu, Q. Yan, D. Sassoon, J. Kitajewski. 1996. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 122:2251.[Abstract]
  56. Henrique, D., E. Hirsinger, J. Adam, I. L. Roux, O. Pourquie, D. Ish-Horowicz, J. Lewis. 1997. Maintenance of neuroepithelial progenitor cells by {delta}-Notch signalling in the embryonic chick retina. Curr. Biol. 7:661.[Medline]
  57. Chitnis, A., D. Henrique, J. Lewis, D. Ish-Horowicz, C. Kintner. 1995. Primary neurogenesis in Xenopus embryos regulated by a homologue of the Drosophila neurogenic gene {delta}. Nature 375:761.[Medline]
  58. Morrison, S. J., S. Perez, J. M. Verdi, C. Hicks, G. Weinmaster, D. J. Anderson. 2000. Transient Notch activation initiates an irreversible switch from neurogenesis to gliogenesis by neural crest stem cells. Cell 101:499.[Medline]
  59. Karanu, F. N., B. Murdoch, L. Gallacher, D. M. Wu, M. Koremoto, S. Sakano, M. Bhatia. 2000. The Notch ligand Jagged-1 represents a novel growth factor of human hematopoietic stem cells. J. Exp. Med. 192:1365.[Abstract/Free Full Text]
  60. Shalaby, F., J. Rossant, T. P. Yamaguchi, M. Gertsenstein, Z.-F. Wu, M. L. Breitman, A. C. Schuh. 1995. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62.[Medline]
  61. Ziegler, B., M. Valtieri, G. Porada, R. De Maria, R. Muller, B. Masella, M. Gabbianelli, I. Casella, E. Pelosi, T. Bock, et al 1999. KDR receptor: a key marker defining hematopoietic stem cells. Science 285:1553.[Abstract/Free Full Text]
  62. Katoh, O., H. Tauchi, K. Kawaishi, A. Kimura, Y. Satow. 1995. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res. 55:5687.[Abstract/Free Full Text]
  63. Yamada, Y., H. Shisa, H. Matsushiro, T. Kamoto, Y. Kobayashi, A. Kawarai, H. Hiai. 1994. T lymphomagenesis is determined by a dominant host gene thymic lymphoma susceptible mouse-1 (TLSM-1) in mouse models. J. Exp. Med. 180:2155.[Abstract/Free Full Text]
  64. el-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 19:817.
  65. Bai, C., R. Richman, S. J. Elledge. 1994. Human cyclin F. EMBO J. 13:6087.[Medline]
  66. Van Lohuizen, M., S. Verbeek, P. Krimpenfort, J. Domen, C. Saris, T. Radaszkiewicz, A. Berns. 1989. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 56:673.[Medline]
  67. Allen, J. D., E. Verhoeven, J. Domen, M. van der Valk, A. Berns. 1997. Pim-2 transgene induces lymphoid tumors, exhibiting potent synergy with c-myc. Oncogene 15:1133.[Medline]
  68. Katzav, S., D. Martin-Zanca, M. Barbacid. 1989. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J. 8:2283.[Medline]



This article has been cited by other articles:


Home page
 J. Immunol.Home page
S. Avagyan, L. Glouchkova, J. Choi, and H.-W. Snoeck
A Quantitative Trait Locus on Chromosome 4 Affects Cycling of Hematopoietic Stem and Progenitor Cells through Regulation of TGF-{beta}2 Responsiveness
J. Immunol., November 1, 2008; 181(9): 5904 - 5911.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. Martelli, B. Ghinassi, B. Panetta, E. Alfani, V. Gatta, A. Pancrazzi, C. Bogani, A. M. Vannucchi, F. Paoletti, G. Migliaccio, et al.
Variegation of the phenotype induced by the Gata1low mutation in mice of different genetic backgrounds
Blood, December 15, 2005; 106(13): 4102 - 4113.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
E. Henckaerts, J. C. Langer, J. Orenstein, and H.-W. Snoeck
The Positive Regulatory Effect of TGF-{beta}2 on Primitive Murine Hemopoietic Stem and Progenitor Cells Is Dependent on Age, Genetic Background, and Serum Factors
J. Immunol., August 15, 2004; 173(4): 2486 - 2493.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
E. Henckaerts, J. C. Langer, and H.-W. Snoeck
Quantitative genetic variation in the hematopoietic stem cell and progenitor cell compartment and in lifespan are closely linked at multiple loci in BXD recombinant inbred mice
Blood, July 15, 2004; 104(2): 374 - 379.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y.-A. Cao, A. J. Wagers, A. Beilhack, J. Dusich, M. H. Bachmann, R. S. Negrin, I. L. Weissman, and C. H. Contag
Shifting foci of hematopoiesis during reconstitution from single stem cells
PNAS, January 6, 2004; 101(1): 221 - 226.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
J. C. Langer, E. Henckaerts, J. Orenstein, and H.-W. Snoeck
Quantitative Trait Analysis Reveals Transforming Growth Factor-{beta}2 as a Positive Regulator of Early Hematopoietic Progenitor and Stem Cell Function
J. Exp. Med., January 5, 2004; 199(1): 5 - 14.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. O. Schonland, C. Lopez, T. Widmann, J. Zimmer, E. Bryl, J. J. Goronzy, and C. M. Weyand
Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages
PNAS, November 11, 2003; 100(23): 13471 - 13476.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. de Haan, L. V. Bystrykh, E. Weersing, B. Dontje, H. Geiger, N. Ivanova, I. R. Lemischka, E. Vellenga, and G. Van Zant
A genetic and genomic analysis identifies a cluster of genes associated with hematopoietic cell turnover
Blood, August 28, 2002; 100(6): 2056 - 2062.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morrison, S. J.
Right arrow Articles by Clarke, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morrison, S. J.
Right arrow Articles by Clarke, M. F.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS